Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way
A Laurenzana, G Fibbi, F Margheri
1Department of Experimental and Clinical Biomedical Sciences, Viale G.B. Morgagni, 50 50134 - Firenze, Italy. delrosso@unifi.it.
Current Molecular Medicine
|September 1, 2015
Summary
Endothelial progenitor cells (EPCs) contribute to new blood vessel formation. Protease systems like MMPs and uPA are key regulators of EPCs in sprouting angiogenesis, offering therapeutic targets for pathological conditions.
Area of Science:
- Biomedical Science
- Cell Biology
- Vascular Biology
Background:
- Sprouting angiogenesis involves vessel expansion and loop formation.
- Endothelial progenitor cells (EPCs) differentiate into mature endothelial cells (ECs) and secrete pro-angiogenic factors.
- EPCs play a crucial vasculogenic role, complementing resident ECs in neovascularization.
Purpose of the Study:
- To review the role of protease systems in controlling EPCs during sprouting angiogenesis.
- To highlight key proteases involved in vascular patterning and EPC mobilization.
- To explore therapeutic potential in regulating these protease systems for pathological angiogenesis.
Main Methods:
- Literature review focusing on protease systems and EPC function in angiogenesis.
- Analysis of the mechanisms by which proteases influence EPC migration, extravasation, and incorporation.
- Discussion of the implications for controlling pathological angiogenesis.
Main Results:
- Protease systems, including matrix-metalloproteinases (MMPs), urokinase-type plasminogen activator (uPA)/uPAR, neutrophil elastase, and cathepsins, are pivotal in regulating EPC behavior.
- These proteases control critical steps such as EPC detachment, intravasation, extravasation, and incorporation into new vessels.
- Dysregulation of these proteases impacts EPC contribution to angiogenesis, particularly in pathological contexts like tumor growth.
Conclusions:
- Protease systems are essential regulators of EPCs in sprouting angiogenesis.
- Targeting these proteases offers a promising strategy for therapeutic intervention in diseases characterized by aberrant angiogenesis.
- Understanding protease involvement can lead to novel treatments for conditions like cancer by controlling pathological neovascularization.
More Related Videos
Related Concept Videos
Mechanism of Angiogenesis
7.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.7K
Regulation of Angiogenesis and Blood Supply
4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Development of Blood Vessels
1.9K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.9K


